semaglutide efficacy weight loss A Real-World Study of the Effectiveness and Safety of for Many Patients Maintain Weight Loss

Loved by Patients Our patients enthusiastic reviews have placed Henry at the top of multiple well established review platforms

Final Verdict: 7 Clinical Facts Ozempic is not licensed for weight loss in the UK Wegovy is the licensed semaglutide weight management product Mounjaro and Wegovy are different drugs tirzepatide (dual GLP-1/GIP) vs semaglutide (GLP-1 only) In the SURMOUNT-5 head-to-head trial, Mounjaro produced 20.2% vs Wegovys 13.7% average weight loss Wegovy is approximately 75/month cheaper at Slinic maintenance doses important for cost-sensitive patients Wegovy has the NICE cardiovascular indication (April 2026) Mounjaro does not yet have this label Wegovy now has a licensed oral version (MHRA June 2026) Mounjaro does not yet have an oral equivalent Neither Ozempic off-label nor compounded alternatives are appropriate when licensed products are readily available from a GPhC-registered UK pharmacy Slinic prescribes Mounjaro and Wegovy both correctly licensed, both from Eli Lilly and Novo Nordisk authorised supply chains, both reviewed by a registered UK prescriber

Researchers might employ this peptide to investigate the chronic impacts of GLP-1 receptor activation on various physiological systems, providing insights into the interconnected nature of metabolic and cardiovascular function

Now, for the first time, it is becoming genuinely cheap in a hugely populous country where all three conditions are widespread and rising

The entire process is completed within one hour